These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 33999535)

  • 1. Shifting the treatment paradigm for patients with deficient mismatch repair colon cancer: is there a role for immunotherapy?
    Kong JC; Flood M; Ramsay RG; Warrier SK; Heriot A
    ANZ J Surg; 2021 May; 91(5):778-780. PubMed ID: 33999535
    [No Abstract]   [Full Text] [Related]  

  • 2. Mismatch repair-deficient colorectal cancer: a model of immunogenic and immune cell-rich tumor despite nonsignificant programmed cell death ligand-1 expression in tumor cells.
    Le Flahec G; Badic B; Guibourg B; Doucet L; Bail JP; Marcorelles P; Schick U; Uguen A
    Hum Pathol; 2018 Feb; 72():135-143. PubMed ID: 29208565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical importance of DNA repair in sporadic colorectal cancer.
    Laporte GA; Leguisamo NM; Kalil AN; Saffi J
    Crit Rev Oncol Hematol; 2018 Jun; 126():168-185. PubMed ID: 29759559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of secreted frizzled-related protein 4 in DNA mismatch repair-deficient and mismatch repair-proficient colorectal cancers].
    Chen K; Liang H; Peng J; Zheng Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Nov; 38(11):1300-1305. PubMed ID: 30514676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficient mismatch repair phenotype is a prognostic factor for colorectal cancer in elderly patients.
    Aparicio T; Schischmanoff O; Poupardin C; Soufir N; Angelakov C; Barrat C; Levy V; Choudat L; Cucherousset J; Boubaya M; Lagorce C; Guetz GD; Wind P; Benamouzig R
    Dig Liver Dis; 2013 Mar; 45(3):245-50. PubMed ID: 23102497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy and metastatic colorectal cancers with microsatellite instability or mismatch repair deficiency.
    Cohen R; Pellat A; Boussion H; Svrcek M; Lopez-Trabada D; Trouilloud I; Afchain P; André T
    Bull Cancer; 2019 Feb; 106(2):137-142. PubMed ID: 30327191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of the sensitivity of metastatic colorectal cancer patients with deficient mismatch repair to standard-of-care chemotherapy and monoclonal antibodies, with recommendations for future research.
    Wensink E; Bond M; Kucukkose E; May A; Vink G; Koopman M; Kranenburg O; Roodhart J
    Cancer Treat Rev; 2021 Apr; 95():102174. PubMed ID: 33721596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Immunotherapy in Microsatellite-Stable or Mismatch Repair Proficient Colorectal Cancer-Fact or Fiction?
    Corcoran RB; Grothey A
    JAMA Oncol; 2020 Jun; 6(6):823-824. PubMed ID: 32379270
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunotherapy Sensitivity of Mismatch Repair-Deficient Cancer: Mutation Load Is Not Enough.
    Gerlinger M
    Cancer Cell; 2021 Jan; 39(1):16-18. PubMed ID: 33434509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Where We Stand With Immunotherapy in Colorectal Cancer: Deficient Mismatch Repair, Proficient Mismatch Repair, and Toxicity Management.
    Overman MJ; Ernstoff MS; Morse MA
    Am Soc Clin Oncol Educ Book; 2018 May; 38():239-247. PubMed ID: 30231358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous Regression of Mismatch Repair-Deficient Colon Cancer: A Case Series.
    Yokota T; Saito Y; Takamaru H; Sekine S; Nakajima T; Yamada M; Sakamoto T; Taniguchi H; Kushima R; Tsukamoto S; Shida D; Kanemitsu Y; Matsuda T
    Clin Gastroenterol Hepatol; 2021 Aug; 19(8):1720-1722.e3. PubMed ID: 32858199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intertumoral Heterogeneity of CD3
    Yoon HH; Shi Q; Heying EN; Muranyi A; Bredno J; Ough F; Djalilvand A; Clements J; Bowermaster R; Liu WW; Barnes M; Alberts SR; Shanmugam K; Sinicrope FA
    Clin Cancer Res; 2019 Jan; 25(1):125-133. PubMed ID: 30301825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy of Colon Cancer.
    Stein A; Folprecht G
    Oncol Res Treat; 2018; 41(5):282-285. PubMed ID: 29705788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogenous loss of mismatch repair (MMR) protein expression: a challenge for immunohistochemical interpretation and microsatellite instability (MSI) evaluation.
    McCarthy AJ; Capo-Chichi JM; Spence T; Grenier S; Stockley T; Kamel-Reid S; Serra S; Sabatini P; Chetty R
    J Pathol Clin Res; 2019 Apr; 5(2):115-129. PubMed ID: 30387329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of defective mismatch repair in adjuvant colon cancer.
    Atkins CD
    J Clin Oncol; 2010 Dec; 28(35):e746; author reply e747. PubMed ID: 21041713
    [No Abstract]   [Full Text] [Related]  

  • 16. [Microsatellite instability (MSI): best predictor of effectiveness of immune checkpoint inhibitors (ICKi)? Focus on MSI by Bulletin du Cancer].
    André T
    Bull Cancer; 2019 Feb; 106(2):91-93. PubMed ID: 30711199
    [No Abstract]   [Full Text] [Related]  

  • 17. Tumor Grade Is Prognostically Relevant Among Mismatch Repair Deficient Colorectal Carcinomas.
    Johncilla M; Chen Z; Sweeney J; Yantiss RK
    Am J Surg Pathol; 2018 Dec; 42(12):1686-1692. PubMed ID: 30179899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mismatch Repair Deficiency as a Predictive Biomarker for Immunotherapy Efficacy.
    Viale G; Trapani D; Curigliano G
    Biomed Res Int; 2017; 2017():4719194. PubMed ID: 28770222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mismatch repair deficient metastatic colon cancer and urothelial cancer: A case report of sequential immune checkpoint therapy.
    Ghatalia P; Nagarathinam R; Cooper H; Geynisman DM; El-Deiry WS
    Cancer Biol Ther; 2017 Sep; 18(9):651-654. PubMed ID: 28726535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of the mismatch repair deficiency of colorectal cancers between African and European cohorts].
    Bienfait L; Doukoure B; Verset L; Demetter P
    Ann Pathol; 2020 Jan; 40(1):12-18. PubMed ID: 31606263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.